vancomycin has been researched along with Recrudescence in 349 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (11.75) | 18.7374 |
| 1990's | 43 (12.32) | 18.2507 |
| 2000's | 69 (19.77) | 29.6817 |
| 2010's | 159 (45.56) | 24.3611 |
| 2020's | 37 (10.60) | 2.80 |
| Authors | Studies |
|---|---|
| Blake, S; Hixon, MS; Janda, KD; Lin, M; Rivera, AJ; Thanissery, R; Theriot, CM | 1 |
| Allerberger, F; Bouza, E; Burns, K; Coia, JE; Fitzpatrick, F; Goorhuis, A; Guery, B; Hristea, A; Krutova, M; Kuijper, EJ; Norén, T; Ooijevaar, RE; Reigadas, E; Scharvik Olesen, BR; Tschudin-Sutter, S; van Prehn, J; van Rossen, TM; Vehreschild, MJGT; Vogelzang, EH; Wilcox, MH | 1 |
| Bazazhina, A; Najjar-Debbiny, R; Saliba, W; Schwartz, N; Shaked, P; Weber, G | 1 |
| Calais, LA; Climo, MW; Donskey, CJ; Ge, L; Gerding, DN; Goetz, MB; Goldberg, AM; Gordin, FM; Gupta, K; Haegerich, T; Johnson, M; Johnson, N; Johnson, S; Li, X; Reda, DJ; Ringer, R | 1 |
| Armiñanzas Castillo, C; Cano Yuste, A; Cobo Reinoso, J; De La Torre Cisneros, J; Díaz Pollán, B; Escudero-Sanchez, R; Fernández Fradejas, J; García Basas, L; García Fernández, S; Giner, L; Gutierrez Rojas, A; Gutiérrez, B; López Medrano, F; Martín Segarra, O; Merino De Lucas, E; Muriel García, A; Olmedo Sampedrio, M; Ramos Martínez, A; Rodríguez Hernández, MJ; Rodríguez-Pardo, D; Ruíz Ruigomez, M; Sáez Bejar, C; Salavert Lletí, M; Tasias Pitarch, M; Valencia Alijo, A | 1 |
| Aftandilian, CC; Agyeman, PKA; Castagnola, E; Chirra, KM; Dupuis, LL; Groll, AH; Haeusler, GM; Lehrnbecher, T; Loves, R; Phillips, B; Schneider, C; Sung, L; van de Wetering, M | 1 |
| Budi, ND; Godfrey, JJ; Rose, WE; Safdar, N; Shukla, SK | 1 |
| Chen, Y; Gu, S; Li, L; Lv, L; Quan, J; Wu, Z; Xu, Q; Zhang, S; Zheng, B | 1 |
| Appaneal, HJ; LaPlante, KL; Liao, JX; Vicent, ML; Vyas, A | 1 |
| Allegretti, J; Chang, LL; Dubberke, ER; Skinner, AM | 1 |
| Farraye, FA; Hashash, JG; Khanna, S; Koop, AH; Pardi, DS; Travers, PM | 1 |
| Bi, Z; Chen, C; Hamilton, MJ; Khoruts, A; Roy, S; Sadowsky, MJ; Su, R; Zhang, L; Zhou, Y | 1 |
| Cacace, J; Goldman, DL; Lee, P; Nemati, K; Silver, EJ | 1 |
| Chow, A; Lye, DC; Ng, TM; Tay, HL | 1 |
| English, M; Fukushima, A; Okumura, H; Shoji, S; Taieb, V | 1 |
| Gasbarrini, A; Gisbert, JP; Hold, GL; Malfertheiner, P; Megraud, F; O'Morain, C; Rokkas, T; Tilg, H | 1 |
| Allegretti, JR; Bry, L; Gerber, GK; Kennedy, K; Marcus, J; Sitko, J; Storm, M | 1 |
| Atamna, A; Avni, T; Ayada, G; Babitch, T; Ben-Zvi, H; Bishara, J; Hijazi, R | 1 |
| Andersen, M; Lei, DK; Ollech, JE; Rubin, DT; Sossenheimer, P; Weisshof, R; Zmeter, N | 1 |
| Chen, YX; Li, HY; Li, L; Liu, C; Lv, PP; Wang, Y; You, JX; Zhao, F; Zhu, WF | 1 |
| Chan, PKS; Jiang, X; Lee, WH; Ng, SC; You, JHS | 1 |
| Gandhi, TN; Malani, PN | 1 |
| Kimura, T; Stanhope, S; Sugitani, T | 1 |
| English, M; Okumura, H; Shoji, S; Ueyama, M | 1 |
| Abutaleb, NS; Seleem, MN | 1 |
| Atalla, E; Mylonakis, E | 1 |
| Gao, L; Li, Y; Liu, G | 1 |
| Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H | 1 |
| Alrahmany, D; El Nekidy, WS; Ereshefsky, BJ; Ghazi, IM; Pontiggia, L | 1 |
| Gutin, LS; Lam, AY; Nguyen, Y; Velayos, FS | 1 |
| Bernstein, CN; Kao, D; Lee, C; Rubin, DT; Shaffer, SR; Singh, H; Smieliauskas, F; Targownik, LE; Witt, J | 1 |
| Benes, J; Capek, V; Krutova, M; Polivkova, S; Sykorova, B | 1 |
| Abad, D; Alfaro, E; Cañamares, P; García, S; Hernández, M; Hijos, G; Laredo, V; Lorente, S; Saura, N; Velamazán, R | 1 |
| Campbell, DL; Gentry, CA; Williams, RJ | 1 |
| Coe, K; Reed, EE; Rinaldi, A; Smith, JM; Stevenson, KB | 1 |
| Bidell, MR; Bratek, BR; Duru, OO; Mitchell, CL; Novak, GM; O'Donnell, JN; Roddy, KM; Singh, G | 1 |
| Andersen, CØ; Bytzer, P; Chehri, M; Engberg, J; Helms, M; Heno, KK; Jensen, US; Krogsgaard, LR; Petersen, AM; Ribberholt, I; Rode, AA; Schønning, K; Svendsen, AT; Tvede, M | 1 |
| Chiu, CW; Hung, YP; Ko, WC; Lee, CC; Tsai, PJ | 1 |
| Shin, JH; Warren, CA | 1 |
| Cao, L; Guo, W; Ji, B; Mu, W; Xu, B; Zhang, X | 1 |
| Alcalá, L; Bouza, E; de Egea, V; González-Del Vecchio, M; Marín, M; Muñoz, P; Reigadas, E; Valerio, M | 1 |
| Axelrad, JE; Green, PHR; Joelson, A; Lawlor, G; Lebwohl, B; Lichtiger, S; Nobel, YR | 1 |
| Bryan, M; Gerber, JS; Hamdy, RF; Hersh, AL; Hsu, AJ; Olson, JA; Stockmann, C; Tamma, PD | 1 |
| Allen, S; DiBaise, JK; Griesbach, CL; Hartmann, CA; Kosiorek, HE; Orenstein, R; Patron, RL | 1 |
| Bachmann, O; Dersch, P; Solbach, P | 1 |
| Gerding, DN; Johnson, S; Lum, J; Manzo, C; Sirbu, BD; Soriano, MM | 1 |
| Leidi, F; Wu, MA | 1 |
| Anderson, FA; Ayturk, MD; Collins, CE; Psoinos, CM; Santry, HP | 1 |
| Eckmann, L; Fuhrmann, V; Manthey, CF | 1 |
| Blanco, N; Eisenberg, MC; Foxman, B; Malani, AN; Rickard, AH; Walk, S; Zhang, M | 1 |
| Carignan, A; Couture-Cossette, A; Ilangumaran, S; Valiquette, L | 1 |
| Boyle, E; Galperine, T; Guery, B; Héquette-Ruz, R; Herbaux, C; Robin, C | 1 |
| Descourouez, JL; Jorgenson, MR; Kerstenetzky, L; Leverson, GE; Redfield, RR; Saddler, CM; Safdar, N; Smith, JA; Splinter, LE | 1 |
| Iguchi, M; Kuzuya, T; Mikamo, H; Morioka, H; Yagi, T | 1 |
| Burton, HE; Mitchell, SA; Watt, M | 1 |
| Gow, P; Hey, P; Johnson, P; Lokan, J | 1 |
| Aoyama, N; Dorr, MB; Fujimoto, G; Mikamo, H; Sawata, M; Yoshinari, T | 1 |
| Cossrow, N; Dorr, MB; Dubberke, ER; Elbasha, E; Jiang, Y; Marcella, S; Prabhu, VS | 1 |
| Kupiec, KE; Liu, C; Miller, JL; Schmidt, SA; Skrepnek, GH; Smith, WJ; Tieu, JD | 1 |
| Jamot, S; Kelly, CR; Lim, SH; Patel, K; Raghunathan, V | 1 |
| Amat, C; Carrera, L; Corona, PS; Lalanza, M; Vicente, M | 1 |
| Aderman, CM; Bhisitkul, RB; Chao, DL; Chiu, CS; Obeid, A; Schwartz, DM | 1 |
| Abe, K; Furukawa, K; Ishida, Y; Sakamoto, T; Shiba, H; Yanaga, K | 1 |
| Anders, S; Garcia-Diaz, J; Hand, J; Li, J; Nguyen, CT; Staffeld-Coit, C | 1 |
| Goyal, H; Perisetti, A; Rehman, MR; Singla, U | 1 |
| Dorr, MB; Dubberke, ER; Ellison, MC; Eves, K; Gerding, DN; Guris, D; Hanson, ME; Kao, D; Kelly, CP; Kumar, PN; Lee, C; Rahav, G; Yacyshyn, B | 1 |
| Alarcon Velasco, SV; Mbaebie, NC; Touhey, J | 1 |
| Cornely, OA; De Nigris, E; Goldenberg, SD; McCrea, C; Watt, M | 1 |
| Drennan, K; Fabian, J; Gaylard, PC; Hepple, A; Karlsson, K; Lee, S; Lowman, W; McNamara, L; Simons, G | 1 |
| Archuleta, S; Chan, YFZ; Kalimuddin, S; Low, JGH; Lye, DC; Ong, SP; Phillips, R; Tan, TT | 1 |
| Barbosa, KVBD; Chebli, JMF; Chebli, LA; Costa, LA; da Rocha Ribeiro, TC; de Almeida Cruz, W; de Assis, IC; de Lima Pace, FH; Gaburri, PD; Garcia, PG; Moraes, BRM; Zanini, A | 1 |
| Gamo, K; Hashimoto, A; Kato, K; Kusachi, S; Mikamo, H; Miki, T; Oizumi, Y; Takesue, Y; Tateda, K; Toyoshima, J; Yanagihara, K | 1 |
| Chalfin, DB; Delgado, D; Fraser, TG; Lam, SW; Neuner, EA | 1 |
| Enoki, Y; Igarashi, Y; Kunishima, H; Matsumoto, K; Mikamo, H; Mori, N; Morinaga, Y; Nakamura, A; Ohge, H; Suzuki, H; Taguchi, K; Tashiro, S; Yamagishi, Y; Yanagihara, K; Yoshizawa, S | 1 |
| Cifu, AS; Gupta, A; Khanna, S | 1 |
| Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
| Gandhi, S; Patel, D; Sohal, S | 1 |
| Cho, S; Dubinsky, MC; Grinspan, A; Hirten, R; Spencer, E | 1 |
| Gentry, CA; Skrepnek, GH; Tieu, JD; Williams, RJ | 1 |
| Gentry, CA; Kurdgelashvili, G; Nguyen, PK; Skrepnek, GH; Thind, S; Williams, RJ | 1 |
| Dahl Jørgensen, SM; Dahlerup, JF; Erikstrup, C; Hansen, MM; Hvas, CL; Jørgensen, SP; Lemming, L; Storgaard, M | 1 |
| Abouanaser, S; Beckett, P; Lee, C; Smieja, M; Stankus, V; Zhang, K | 1 |
| Boyanova, L; Hadzhiyski, P; Markovska, R; Mitov, I; Yaneva, P; Yordanov, D | 1 |
| Alowami, S; Chin-Yee, B; El-Helou, P; Gangji, A; Lee, S; Lo, CK; Ribic, C; Wang, MK | 1 |
| Adomakoh, N; Cornely, OA; Georgopali, A; Guery, B; Karas, A; Kazeem, G; Vehreschild, MJGT | 1 |
| Lee, SJ; Lee, SU; Nam, KY; Noh, GM; Park, ID | 1 |
| Kimura, T; Snijder, R; Sugitani, T | 1 |
| Calderwood, MS; Caroff, DA; Klompas, M; Kubiak, DW; Menchaca, JT; Rhee, C; Yokoe, DS; Zhang, Z | 1 |
| Berthiller, J; Chardot, C; Duclaux-Loras, R; Ferroni, A; Goulet, O; Lacaille, F; Norsa, L | 1 |
| Bryson-Cahn, C; Chan, JD; Jain, R; Liu, C; Lynch, JB | 1 |
| Baines, SD; Camacho-Ortíz, A; Flores-Treviño, S; Garza-González, E; Maldonado-Garza, H; Morfín-Otero, R; Rodríguez-Noriega, E; Tijerina-Rodríguez, L; Villarreal-Treviño, L | 1 |
| Horbal, J; Hostoffer, R; Jhaveri, D; Marino, J; Sterbank, J; Tcheurekdijian, H; Tcheurekdjian, H | 1 |
| Chan, JY; Elliott, AJ; Ellis, SJ | 1 |
| Eisenbach, C; Mischnik, A; Sandig, C; Steinebrunner, N; Stremmel, W; Zimmermann, S | 1 |
| Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E | 1 |
| Bass, SN; Bauer, SR; Lam, SW; Neuner, EA | 1 |
| Ebigbo, A; Messmann, H | 1 |
| John, E; Lippmann, N; Lübbert, C; Mössner, J; Weis, S | 1 |
| Barro, V; Cáceres, E; Corona, PS; Flores, X; Mendez, M | 1 |
| Aires, D; Jibbe, A; Liu, D; Tefft, K; Weir, G | 1 |
| Cioara, A; Filipescu, I; Flonta, M; Lupse, M; Todor, N | 1 |
| Collins, SH; D'Agostino, RB; Gorbach, S; Kean, Y; Pencina, KM | 1 |
| Chow, KM; Kwan, BC; Lee, KP; Leung, CB; Li, PK; Ma, TK; Szeto, CC | 1 |
| Broom, C; Chasan-Taber, S; Cornely, OA; Davidson, DM; Fitts, D; Gelone, SP; Gerding, DN; Johnson, S; Louie, TJ | 1 |
| Cosler, L; Drusano, GL; El-Fawal, N; Evans, A; Graffunder, E; Jones, RN; Lazariu, V; Lodise, TP; McNutt, LA; Mendes, RE; Stellrecht, K | 1 |
| Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M | 1 |
| Aitken, SL; DuPont, HL; Garey, KW; Joseph, TB; Lasco, TM; Palmer, HR; Shah, DN; Xie, Y | 1 |
| Chen, Z; Cheng, H; Deng, QW; Pan, WG; Yang, WZ; Yu, ZJ; Zheng, JX | 1 |
| Díaz-Domínguez, M; Quereda-Rodríguez-Navarro, C; Rivera-Gorrin, M; Rodríguez-Mendiola, N; Ruiz-Roso, G; Teruel-Briones, JL | 1 |
| Dees, A; Jonkman, JG; van Genderen, ME; van Rijn, M | 1 |
| Johnson, S; Soriano, MM | 1 |
| Keller, JJ; Kuijper, EJ | 1 |
| Payne, L; Sattar, A; Thommes, P; Vickers, RJ; Warn, P | 1 |
| Christenson, ES; Hsu, S; Ligon, C | 1 |
| Dubberke, ER; Olsen, MA; Reske, KA; Yan, Y; Zilberberg, M | 1 |
| Liu, W; Lv, Z; Peng, G; Su, J; Xu, H | 1 |
| Alm, E; Burgess, J; Burns, L; Didyk, E; Edelstein, C; Giovanelli, A; Kassam, Z; Mendolia, G; Noh, A; Smith, M; Stollman, N | 1 |
| Ananthakrishnan, AN; Barber, GE; Wen, J | 1 |
| Chilton, CH; Crowther, GS; Freeman, J; Nicholson, S; Todhunter, SL; Wilcox, MH | 1 |
| Carreiro, FT; Coelho, SC; Horta, AB; Sá, J | 1 |
| Cury, JD; Dakkak, M; Siddiqi, F | 1 |
| Vaishnavi, C | 1 |
| Marra, F; Ng, K | 1 |
| Acuña, G; Moscoso, F; Quera, R; Rivera, D; Simian, D | 1 |
| Doron, S; Gorbach, S; Mizusawa, M | 1 |
| Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Kracker, H; Louie, T; Nord, CE; Talbot, GH; Wilcox, M | 1 |
| Greenberg, A; Matta, SK; Singh, A | 1 |
| Al Hamal, Z; Chaftari, AM; El Zakhem, A; Gagel, A; Garoge, K; Granwehr, B; Hachem, R; Jiang, Y; Jordan, M; Mulanovich, V; Raad, I; Reitzel, R; Viola, GM; Yousif, A | 1 |
| Jacobson, SM; Slain, D | 1 |
| Abou Chakra, CN; Marcil-Héguy, A; Nault, V; Pépin, J; Sheitoyan-Pesant, C; Valiquette, L | 1 |
| Adamson, R; Bauer, K; Bensman, J; Chaudhry, SB; Culshaw, DL; Eskandarian, R; Goff, DA; Lamp, KC; Leuthner, K; Lodise, T; McKinnell, JA; Moise, PA; Reyes, K; Smith, WJ; Virata, MD; Wong-Beringer, A; Zervos, MJ | 1 |
| Chilton, CH; Crowther, GS; Ewin, D; Karas, A; Longshaw, C; Todhunter, SL; Vernon, J; Wilcox, MH | 1 |
| Almeida, DR; Chin, EK; Mahajan, VB | 1 |
| Han, WD; Kang, YM; Kim, ES; Kim, HB; Kim, NH; Kim, NJ; Lee, DG; Oh, MD; Park, C; Park, KH; Park, KU; Park, SW; Song, KH; Yoo, JI | 1 |
| Brain, D; Connelly, LB; Graves, N; Merlo, G | 1 |
| Baloun, B; Gilbert, J; Nelson, C; Wiedel, N | 1 |
| Beneš, J; Polívková, S | 1 |
| Cantón, R; Del Campo, R; Fortun, J; Morosini, MI; Ponce-Alonso, M | 1 |
| Brodsky, D; Halevi, CN; Nitzan, O; Pastukh, N; Peretz, A; Tkhawkho, L | 1 |
| Bonavila Juan, C; Goenaga Sánchez, MÁ; Michelena Bengoechea, A; Zubeltzu Sese, B | 1 |
| Telekes, A | 1 |
| Chesnel, L; Lee, CH; Louie, T; Mullane, KM; Patino, H; Rege, S; Stevens, C | 1 |
| Dezsenyi, B; Fried, K; Gergely Szabo, B; Kadar, B; Kamotsay, K; Kunovszki, P; Nikolova, R; Prinz, G; Szidonia Lenart, K | 1 |
| Al-Bachari, H; Carignan, A; Labbé, AC; Martin, P; Montpetit, LP; Pépin, J; Poulin, S; Valiquette, L | 1 |
| Boccuzzi, E; Borali, E; Castellazzi, L; Cursi, L; De Giacomo, C; De Vita, MV; Esposito, S; Garazzino, S; Guarino, A; Lancella, L; Lo Vecchio, A; Mainetti, M; Tagliabue, C | 1 |
| Kim, SH; Lee, J; Yoo, RN | 1 |
| Fashandi, AZ; Friel, CM; Hallowell, PT; Hays, RA; Hedrick, TL; Martin, AN; Smith, PW; Wang, PT | 1 |
| Coburn, B; Guttman, DS; Hota, SS; Low, DE; McGeer, A; Poutanen, SM; Sales, V; Salpeter, MJ; Tomlinson, G | 1 |
| Baro, E; Denies, F; Dervaux, B; Galperine, T; Guery, B; Lannoy, D; Lenne, X; Odou, P | 1 |
| Dinh, A; Le Monnier, A; Tilleul, P; Watt, M | 1 |
| Brewer, J; Bulchandani, D; Fitzsimmons, C; Jost, P; Nachnani, J | 1 |
| Baratz, M; Ehrlich, GD; Gahlot, V; Johnson, S; Kathju, S; Lasko, LA; Nistico, L; Stoodley, P | 1 |
| Bartelsman, JF; Jansen, JM; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; van Heukelem, HA; van Nood, E; Visser, CE | 1 |
| Fujinaga, S; Hirano, D; Kaneko, K; Nishizaki, N; Ohtomo, Y; Ohtsuka, Y; Shimizu, T; Someya, T | 1 |
| Camplese, P; Iarussi, T; Marolla, A; Pardolesi, A; Patea, RL; Sacco, R | 1 |
| Balázs, G; Ivády, B; Liptai, Z; Ujhelyi, E | 1 |
| Castagnini, LA; DiCaprio, HS; Julapalli, MR; Peña, JA; Phelps, BR; Pirics, ML; Tolle, MA | 1 |
| Bujanda, L; Cosme, A | 1 |
| Kelly, CP | 2 |
| Altman, A; Paz, Z | 1 |
| Johnson, S | 1 |
| Dang, S; Davies, D; Sigal, Y | 1 |
| Chow, KM; Chung, KY; Kwan, BC; Law, MC; Leung, CB; Li, PK; Pang, WF; Szeto, CC | 1 |
| Candinas, D; Inderbitzin, D; Keller, M; Keogh, A; Mennicke, M; Pichler, WJ; Stickel, F; Wilkens, L; Yawalkar, N; Zawodniak, A | 1 |
| Schlaudecker, JD | 1 |
| Fisher, S; Levy, I; Livni, G; Megged, O; Shalit, I; Yaniv, I | 1 |
| Scheppach, W | 1 |
| Aas, J; Gessert, CE; Rubin, TA | 1 |
| Bozic, KJ; Kalra, KP; Lin, KK; Ries, MD | 1 |
| Grajek, S; Ozorowski, T; Straburzyńska-Migaj, E; Trojnarska, O; Łanocha, M | 1 |
| Banaszkiewicz, A; Brazier, JS; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; van Belkum, A; Wultańska, D | 1 |
| Jeong, JB; Jung, HC; Kim, BG; Kim, JS; Kim, JW; Lee, KL; Shin, S; Song, IS | 1 |
| Salkind, AR | 1 |
| Balne, PK; Bhatia, K; Mathai, A; Reddy, AK; Reddy, BV; Sambhav, K | 1 |
| Bargman, JM; Heywood, A | 1 |
| Alexander, J; Surawicz, CM | 1 |
| Misawa, Y; Morita, H; Oki, S; Saito, T | 1 |
| Choi, HK; Kim, KH; Lee, SH; Lee, SJ | 1 |
| Abbott, AN; Armitige, LY; Gardiner, JM; Kruzel, MC; Lewis, CT; Lewis, EM; Mohr, JF; Skrobarcek, KA; Wanger, A; Welsh, KJ | 1 |
| Amundson, WH; Decarolis, DD; Drekonja, DM; Johnson, JR; Kuskowski, MA; Lederle, FA | 1 |
| LaZear, R; Nayfeh, TA; Roy, ME; Whiteside, LA | 1 |
| Gardner, E; Mancuso, P; Meghani, N; Thomson, A | 1 |
| Eskandarian, R; Jobson, S; Moise, PA | 1 |
| Kang, JO; Kim, J; Pai, H; Seo, MR | 1 |
| Baban, TA; El-Herte, RI; Kanj, SS | 1 |
| Jahamy, H; Johnson, LB; Khatib, R; Patel, SM; Riederer, K; Shemes, SP; Szpunar, S; Valenti, S; Venugopal, AA | 1 |
| Bernard, L; Buzzi, M; Ferry, T; François, P; Harbarth, S; Huggler, E; Lew, DP; Renzoni, A; Schrenzel, J; Uçkay, I; Vaudaux, P | 1 |
| Bliss, D; Butler, M; Drekonja, DM; Filice, GA; MacDonald, R; Rector, TS; Wilt, TJ | 1 |
| Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG | 1 |
| Falagas, ME; Patouni, K; Polyzos, KA; Rafailidis, PI; Samonis, G; Vardakas, KZ | 1 |
| Aroniadis, OC; Brandt, LJ; Kanatzar, A; Kelly, C; Mellow, M; Park, T; Rohlke, F; Stollman, N; Surawicz, C | 1 |
| Babakhani, F; Cheknis, A; Gerding, DN; Johnson, S; Kean, Y; Nagaro, K; Petrella, LA; Sambol, SP; Sears, PS | 1 |
| Armbruster, S; Goldkind, L | 1 |
| Lamarche, MJ; Leeds, JA; McKenney, D; Praestgaard, J; Trzasko, A | 1 |
| Cheema, FH; Kanwal, S; Korsten, MA; Luthra, M; Majeed, UM; Rafiullah, F; Sohail, MR | 1 |
| Barber, N; Franklin, BD; Shebl, NA | 1 |
| Finnegan, PM; Linneman, TW; McDonald, JR; Moenster, RP | 1 |
| Babakhani, F; Citron, DM; Goldstein, EJ | 1 |
| Bauer, MP; Dale, AP; Fawley, WN; Gerding, DN; Gorbach, SL; Hensgens, MP; Kuijper, EJ; Miller, MA; Wilcox, MH | 1 |
| Carchman, EH; Nassour, I; Simmons, RL; Zuckerbraun, BS | 1 |
| Kim, SW | 1 |
| Gerding, DN; Johnson, S | 1 |
| Abdelghany, O; Ruggero, MA; Topal, JE | 1 |
| Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P | 1 |
| Ha, D; Tsai, CJ | 1 |
| Cornely, OA | 1 |
| Brandt, C; Clare, S; Clark, TG; Connor, TR; Deakin, LJ; Dougan, G; Duncan, SH; Flint, HJ; Goulding, D; Lawley, TD; Parkhill, J; Pickard, DJ; Rad, R; Raisen, C; Schreiber, F; Stares, MD; Walker, AW | 1 |
| Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA | 1 |
| Barshes, NR; Bechara, CF; Darouiche, RO; Kougias, P; Lin, PH; Pisimisis, G; Poi, MJ | 1 |
| Bartelsman, JF; de Vos, WM; Dijkgraaf, MG; Fuentes, S; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; Tijssen, JG; van Nood, E; Visser, CE; Vrieze, A; Zoetendal, EG | 1 |
| Li, Y; Qian, J; Queener, E; Shen, B | 1 |
| Elmer, GW; McFarland, LV; Surawicz, CM | 1 |
| Chiang, RK; Rapuano, CJ | 1 |
| Hesse, Y; Lang, GK; Spraul, CW | 1 |
| Alcázar Montero, MS; Gimeno Aranguez, M; Navarro Gaspar, C; Vilalta Castel, E | 1 |
| Lenzen-Grossimlinghaus, R; Strohmeyer, G | 1 |
| Hoaglund, PA; Shoultz, DA; Tice, AD | 1 |
| Federman, DG; Kravetz, JD | 1 |
| Martirosian, G; Szczesny, A | 1 |
| Domínguez, I; García Serrano, JL; Serrano Laborda, D | 1 |
| Barker, TA; Clarke, B; Denley, H; Grötte, GJ; Kadir, IS | 1 |
| Baker, SD; Horger, DC; Keane, TE | 1 |
| Oldfield, EC | 1 |
| Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM | 1 |
| Au Eong, KG; Chee, CK; Lee, JJ; Teoh, SC | 1 |
| Gerding, DN | 1 |
| Alary, ME; Bourassa, C; Fulop, K; Godin, D; Pepin, J; Raiche, E; Ruel, J; Valiquette, L | 1 |
| Giladi, M; Orni-Wasserlauf, R; Reich, P; Schwartz, D; Siegman-Igra, Y | 1 |
| Altaş, K; Bağdatli, Y; Bahar, H; Demirci, M; Hiramatsu, K; Kapi, M; Kocazeybek, B; Torun, MM | 1 |
| Bac, DJ; Dingemans-Dumas, AM; Visser, WE | 1 |
| Corne, P; Jonquet, O; Macia, JC; Marchandin, H | 1 |
| Cabrera, D | 1 |
| Ichinose, Y; Kakeji, Y; Maehara, Y; Yamaguchi, M; Yoshino, I | 1 |
| Cohen, RA; Eliopoulos, GM; Gold, HS; Moellering, RC; Sakoulas, G; Venkataraman, L | 1 |
| Lin, SF; Yang, WC | 1 |
| Hart, WJ; Jones, RS | 1 |
| Bhavani, SS; Pettersson, GB; Rehm, SJ; Slisatkorn, W | 1 |
| Cicogna, CE; Kuyumjian, AG; Surowiec, D; Wynd, MA | 1 |
| Chen, YH; Dickerman, RD; Kattner, KA; Noel, J; Seibly, JM; Stevens, QE | 1 |
| Heins, JR | 1 |
| Hornillos Calvo, M; Pareja Sierra, T | 1 |
| Pakyz, A | 1 |
| Das, A; Ge, Y; Talbot, GH; Thye, D | 1 |
| Nazarko, L | 1 |
| Brazeau, I; Gagnon, S; Pépin, J; Routhier, S; Valiquette, L | 1 |
| Arnell, K; Enblad, P; Sjölin, J; Wester, T | 1 |
| Shen, EP; Surawicz, CM | 1 |
| Al-Nammari, SS; Lam, KS; Lucas, JD | 1 |
| Gerding, DN; Muto, CA; Owens, RC | 1 |
| McCracken, GH; Mohs, E; Nelson, JD; Odio, C; Sklar, FH | 1 |
| Bartlett, JG | 1 |
| Burdon, DW | 1 |
| Baer, M; Grönroos, P; Mäki, M; Vesikari, T | 1 |
| Bartlett, JG; Chang, T; Lowe, B; Shull, S; Tedesco, FJ | 1 |
| Tedesco, FJ | 1 |
| LaMont, JT; Trnka, YM | 1 |
| Meuwissen, SG; Mulder, CJ; Reiss, M; Rietra, PJ; Van Leeuwen, AM; Visser, J | 1 |
| Rampling, A; Swayne, RL; Warren, RE | 1 |
| Bartlett, JG; Moskovitz, M | 1 |
| Murray, D; Portnoy, D; Richards, GK; Soneji, A | 1 |
| Baird, I; Batts, DH; Fekety, R; Plouffe, JF; Rifkin, GD; Silva, J | 1 |
| Bartlett, JG; Chang, TW; Gorbach, SL; Saginur, R | 1 |
| Moore, B; Philpot, CR; Rich, G; Wilkinson, IJ | 1 |
| Bowman, RA; Riley, TV | 1 |
| Roberts, RK; Seneviratne, E | 1 |
| Rampling, A; Sykes, HV; Warren, RE | 1 |
| Chan, SM; Chia, JK; Goldstein, H | 1 |
| Braden, GL; Germain, MJ; Lipkowitz, GS; Madden, RL; Mulhern, JG; O'Shea, MH | 1 |
| Caron, F; Gutmann, L; Humbert, G; Kitzis, MD; Lemeland, JF; Pestel, M | 1 |
| Cartmill, TD; Keith, E; McCann, DC; Nice, CN; Panigrahi, H; Worsley, MA | 1 |
| Messick, CR; Reinke, CM | 1 |
| Andremont, A; Boasson, M; Cordonnier, C; Herbrecht, R; Kazmierczak, A; Leverger, G; Marie, JP; Marit, G; Miclea, JM; Schlemmer, B | 1 |
| Hoppen, T; Keller, KM; Rister, M; Stolte, M | 1 |
| García, D; Javaloyas, M; Ruffi, G | 1 |
| Henrickson, KJ; Sheth, KJ | 1 |
| Klaus, G; Mehls, O; Müller-Wiefel, D; Schaefer, F | 1 |
| Bacino, A; Bonatti, L; Borello, G; Galliano, R; Lorenzini, L; Marchesa, P; Massaioli, N | 1 |
| Aljundi, H; Held, M; Khatib, R; Riederer, KM | 1 |
| Schweitzer, MA; Silver, DL; Stellato, TA; Sweiss, I | 1 |
| Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C | 1 |
| Brown, CW; Chow, GH; Gebhard, JS | 1 |
| Fujita, K; Kato, H; Kato, N; Sakata, Y; Ueno, K; Watanabe, K | 1 |
| Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Mulligan, ME; Surawicz, CM | 1 |
| Johnson, JA; Morris, JG; Qaiyumi, S; Roghmann, MC; Schwalbe, R | 1 |
| Casewell, MW; Rolando, N; Wade, JJ; Williams, R | 1 |
| Piraino, B | 1 |
| Kelly, CP; LaMont, JT | 1 |
| Ayyala, RS; Fouraker, BD; Grizzard, WS; Stevens, SX | 1 |
| Hargrave, J; Roberts, RB; Serur, D; Sieradzki, K; Tomasz, A | 2 |
| Aziz, NS; Gendeh, BS; Gibb, AG; Kong, N; Zahir, ZM | 1 |
| Dan'ura, T; Inoue, H; Kunisada, T; Naito, N; Ozaki, T; Yoshitaka, T | 1 |
| Corpuz, M; Nair, S; Pitchumoni, CS; Yadav, D | 1 |
| Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Rubin, M; Surawicz, CM | 1 |
| Alvarez-Grande, J; Baltar, J; Díaz-Corte, C; Gago, E; Peces, R | 1 |
| Müller-Wiefel, DE | 1 |
| Antoine, C; Arfi, C; Desgrippes, A; Fournier, R; Le Duc, A; Martinat, L; Meria, P; Teillac, P | 1 |
| Danko, L; Elmer, GW; Greenberg, RN; McFarland, LV; Surawicz, CM | 1 |
| Aldave, AJ; Deramo, VA; Fischer, DH; Maguire, JI; Shah, GK; Stein, JD | 1 |
| English, BK; McCullers, JA; Novak, R | 1 |
| Chen, JC; Roy, M | 1 |
| Alcantara, CS; Guerrant, RL | 1 |
| Borjal, D; Bowen, K; Brandmarker, S; Elmer, GW; Fekety, R; Garcia, RJ; Greenberg, RN; McFarland, LV; Mulligan, ME; Rubin, M; Surawicz, CM | 1 |
| Ballmer, PE; Bergamin, B; Hess, T; Imoberdorf, R; Jost, R | 1 |
| Duch, JM; Yee, J | 1 |
| Kurup, A; Lin, R; Loo, LH; Tee, WS | 1 |
| Aihara, M; Chiba, T; Hajiro, K; Nishi, A; Sakurai, T; Takakuwa, H | 1 |
| Ahmad, A; Dick, D; Hullin, MG; Skinner, GR; Zafar, A | 1 |
| Kelly, CP; Kyne, L | 1 |
| Chang, JD; Cho, SH; Ha, YC; Kim, SY; Kim, YH; Koo, KH; Park, HB; Song, HR; Yang, JW | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Handke, R; Schmitt-Grohé, S; Steffan, J; Wiggert, E; Zielen, S | 1 |
| Bae, GB; Kang, HR; Kang, YM; Kim, JH; Kim, NS; Kim, SW; Lee, JM; Nam, EJ; Park, JH | 1 |
| Finch, RG; George, RH; Lewis, MJ; Slack, RC; Thomas, HJ | 1 |
| Karchmer, AW; Maki, DG; Moellering, RC; Swartz, MN | 1 |
| Finegold, SM; George, WL; Liechty, EJ; Mok, HY; Richman, DD; Rolfe, RD; Stiner, DB; Volpicelli, NA | 1 |
| Spencer, RC; Wilcox, MH | 1 |
| Anwar, N; Gokal, R; Merchant, MR; Tooth, JA; Uttley, L; Were, A | 1 |
| Klaus, G; Mehls, O; Querfeld, U; Schäfer, F; Soergel, M; Wolf, S | 1 |
| Huang, SC; Kuo, MF; Wang, HS | 1 |
| Dru, M | 1 |
| Lam, TY; Oreopoulos, DG; Vas, SI | 1 |
| Haimann, MH; Miller, JA; Weiss, H | 1 |
| Brandi, L; Ejlersen, E; Haarh, P; Kopp, R; Ladefoged, J; Løkkegaard, H | 1 |
| Flanigan, MJ; Lim, VS | 1 |
| Chambers, HF; Small, PM | 1 |
| Boletis, I; Brown, CB; Cohen, GL; el Nahas, AM; Johnson, BF; Moorhead, PJ; Raftery, AT; Williams, AJ | 1 |
| Ackrill, P; Bowley, JA; Burnie, J; Fleming, SJ; Oppenheim, BA; Pickering, SJ; Ralston, AJ; Sissons, P | 1 |
| Powell, KR; Pruksananonda, P | 1 |
| Coucudis, P; Jafer, H; Jara, F; Kartali, S; Pasadakis, P; Peihaberis, P; Thodis, H; Vargemezis, V | 1 |
| Ben-Ezer Gradus, D; Benjamin, J; Chaimovitz, C; Mostoslavski, M; Rapoport, J | 1 |
| Chinn, J; Elmer, G; McFarland, LV; Surawicz, CM | 1 |
| Brown, E; Hendler, E | 1 |
| Ehni, WF; Reller, LB | 1 |
| Clumeck, N; De Wit, S; Goosens, H; Hermans, P; Van Laethem, Y | 1 |
| DeBenedictis, TH; Gorecki, GA | 1 |
| Chambers, HF; Miller, RT; Newman, MD | 1 |
| Bayley, N; McDonald, MI; St John, DJ; Ward, P; Young, GP | 1 |
| Carrington, G; Dudley, MN; Frick, J; McLaughlin, JC; Nightingale, CH; Quintiliani, R | 1 |
| Elmer, GW; McFarland, LV | 1 |
| Barclay, F; Bonnycastle, M; Borriello, SP; Piper, M; Seal, D; Welch, A | 1 |
| Buggy, BP; Fekety, R; Silva, J | 1 |
| Beart, RW; Talbot, RW; Walker, RC | 1 |
| McDonald, M; Young, G | 1 |
| Fortson, WC; Gordon, D; Tedesco, FJ | 1 |
| Vacek, V | 1 |
52 review(s) available for vancomycin and Recrudescence
| Article | Year |
|---|---|
Path of least recurrence: A systematic review and meta-analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Middle Aged; Recurrence; Vancomycin | 2022 |
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Recurrence; Treatment Outcome; Vancomycin | 2020 |
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Middle Aged; Network Meta-Analysis; Placebos; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Vancomycin | 2019 |
Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability?
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Development; Fidaxomicin; Recurrence; Secondary Prevention; Spores, Bacterial; Vancomycin | 2021 |
Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens.
Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Immunologic Factors; Mice; Recurrence; Vancomycin | 2017 |
[Individualized treatment strategies for Clostridium difficile infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Metronidazole; Recurrence; Secondary Prevention; Vancomycin | 2017 |
Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Design; Humans; Metronidazole; Practice Guidelines as Topic; Recurrence; Severity of Illness Index; Vancomycin | 2017 |
Bezlotoxumab for the prevention of Clostridium difficile recurrence.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Bacterial Proteins; Bacterial Toxins; Broadly Neutralizing Antibodies; Clinical Trials as Topic; Clostridium Infections; Half-Life; Humans; Recurrence; Vancomycin | 2017 |
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; Hospitalization; Humans; Metronidazole; Recurrence; Vancomycin | 2017 |
New and emerging therapies in treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2018 |
Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Fidaxomicin; Health Care Costs; Humans; Monte Carlo Method; Quality-Adjusted Life Years; Recurrence; Vancomycin | 2018 |
Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin | 2018 |
Crusted scabies in a renal transplant recipient treated with daily ivermectin: A case report and literature review.
Topics: Administration, Oral; Aged; Animals; Diagnosis, Differential; Exanthema; Humans; Immunosuppression Therapy; Ivermectin; Kidney Transplantation; Male; Recurrence; Sarcoptes scabiei; Scabies; Sepsis; Skin; Vancomycin | 2019 |
[Clostridium difficile infection: epidemiology, disease burden and therapy].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin | 2013 |
Peritoneal-dialysis related peritonitis caused by Gordonia species: report of four cases and literature review.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Device Removal; Disease Management; Gordonia Bacterium; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Meropenem; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prosthesis-Related Infections; Recurrence; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin | 2015 |
Treatment of recurrent and severe Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Metronidazole; Microbiota; Recurrence; Severity of Illness Index; Transplantation; Vancomycin | 2015 |
Fidaxomicin--the new drug for Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Recurrence; Vancomycin | 2015 |
Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Incidence; Metronidazole; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Probiotics; Recurrence; Risk Factors; Vancomycin | 2015 |
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2015 |
[Recurrent endocarditis due to Brevibacterium casei: case presentation and a review of the literature].
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Brevibacterium; Ceftriaxone; Disease Susceptibility; Drug Therapy, Combination; Emergencies; Endocarditis, Bacterial; Facial Dermatoses; Gentamicins; Humans; Levofloxacin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Recurrence; Tetracycline; Vancomycin; Wound Infection | 2017 |
[Oncologic aspects of Clostridium difficile].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Gastrointestinal Microbiome; Humans; Recurrence; Risk Factors; Vancomycin | 2016 |
[Clostridium-difficile-associated diarrhea].
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Biological Therapy; Clostridioides difficile; Colectomy; Colonoscopy; Combined Modality Therapy; Cross Infection; Diarrhea; DNA, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant, Newborn; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Superinfection; Vancomycin | 2009 |
A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestines; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Severity of Illness Index; Vancomycin | 2009 |
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Treatment Outcome; Vancomycin | 2009 |
[Infections with Clostridium difficile following antibiotic therapy].
Topics: Administration, Oral; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Endoscopy; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Recurrence; Time Factors; Vancomycin | 2009 |
Clostridium difficile: an update for the primary care clinician.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Patient Isolation; Primary Health Care; Probiotics; Recurrence; Severity of Illness Index; Vancomycin | 2010 |
Treatment of refractory and recurrent Clostridium difficile infection.
Topics: Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin | 2011 |
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin | 2012 |
Comparative effectiveness of Clostridium difficile treatments: a systematic review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Comparative Effectiveness Research; Diarrhea; Drug Therapy, Combination; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin | 2011 |
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.
Topics: Anti-Bacterial Agents; Asia; Clostridioides difficile; Clostridium Infections; Europe; Humans; Metronidazole; North America; Recurrence; Treatment Failure; Vancomycin | 2012 |
Current strategies for management of initial Clostridium difficile infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Length of Stay; Metronidazole; Recurrence; Rehabilitation Centers; Risk Factors; Severity of Illness Index; Vancomycin | 2012 |
Novel management strategies in the treatment of severe Clostridium difficile infection.
Topics: Algorithms; Anti-Infective Agents; Colectomy; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Immunization; Metronidazole; Prognosis; Recurrence; Risk Factors; Vancomycin | 2012 |
[Treatment of refractory or recurrent Clostridium difficile infection].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Probiotics; Recurrence; Vancomycin | 2012 |
Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Recurrence; Vancomycin | 2012 |
[Treatment of infections associated with Clostridium difficile].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Species Specificity; Vancomycin | 2003 |
Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification.
Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Vancomycin; Vitrectomy | 2005 |
Past, present, and future therapies for Clostridium difficile-associated disease.
Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Forecasting; Humans; Metronidazole; Probiotics; Recurrence; Vancomycin | 2006 |
Clostridium difficile-associated disease.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Recurrence; Risk Factors; Saccharomyces; Vancomycin | 2006 |
Clostridium difficile: dealing with a silent menace.
Topics: Anti-Bacterial Agents; Antidiarrheals; Clostridioides difficile; Clostridium Infections; Disinfection; Drug Prescriptions; Early Diagnosis; Humans; Incidence; Infection Control; Population Surveillance; Primary Prevention; Recurrence; Risk Factors; United Kingdom; Vancomycin | 2007 |
Treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Disease Management; Enterocolitis, Pseudomembranous; Humans; Metronidazole; North America; Recurrence; Therapies, Investigational; Vancomycin | 2008 |
Antibiotic-associated colitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin | 1984 |
Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1984 |
Update on Clostridium difficile-induced colitis, Part 2.
Topics: Administration, Oral; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Drug Costs; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 1994 |
Multifocal metachronous epidural abscesses of the spine. A case report.
Topics: Abscess; Aged; Cervical Vertebrae; Drainage; Epidural Space; Female; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Recurrence; Retrospective Studies; Spinal Diseases; Staphylococcal Infections; Vancomycin | 1996 |
Infectious complications of peritoneal dialysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Catheterization; Dialysis Solutions; Drug Resistance, Microbial; Equipment Design; Forecasting; Humans; Macrophages, Peritoneal; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Vancomycin | 1997 |
Clostridium difficile infection.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Drug Costs; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Exotoxins; Feces; Hospitalization; Humans; Intestinal Mucosa; Metronidazole; Recurrence; Time Factors; Vancomycin | 1998 |
Update on Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2000 |
Recurrent Clostridium difficile diarrhoea.
Topics: Anion Exchange Resins; Anti-Bacterial Agents; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin | 2001 |
Two episodes of Stenotrophomonas maltophilia endocarditis of prosthetic mitral valve: report of a case and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Bioprosthesis; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Recurrence; Stenotrophomonas maltophilia; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
Clostridium difficile infection: responses, relapses and re-infections.
Topics: Clinical Trials as Topic; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Recurrence; Vancomycin | 1992 |
[Current status of Clostridium difficile: recent advances in diagnostic materials and treatment of colitis and diarrheas associated with antibiotic therapy].
Topics: Causality; Clinical Protocols; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Recurrence; Vancomycin | 1991 |
39 trial(s) available for vancomycin and Recrudescence
| Article | Year |
|---|---|
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; COVID-19; Diarrhea; Fidaxomicin; Humans; Recurrence; Treatment Outcome; Vancomycin | 2022 |
Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections.
Topics: Clostridioides; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Humans; Recurrence; Treatment Outcome; Vancomycin | 2021 |
The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Japan; Male; Metronidazole; Placebos; Recurrence; Time Factors; Vancomycin | 2018 |
Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cost-Benefit Analysis; Female; Humans; Male; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Recurrence; Secondary Prevention; Vancomycin | 2018 |
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Risk Factors; Secondary Prevention; Vancomycin; Young Adult | 2018 |
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; England; Female; Fidaxomicin; Humans; Male; Middle Aged; Quality of Life; Recurrence; Treatment Outcome; Vancomycin | 2018 |
A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cause of Death; Daptomycin; Drug Resistance, Bacterial; Early Termination of Clinical Trials; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Recurrence; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Fidaxomicin; Hospitalization; Humans; Japan; Male; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Denmark; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Male; Middle Aged; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2019 |
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Fidaxomicin; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Ribotyping; Treatment Outcome; Vancomycin | 2019 |
[Challenges of Clostridium difficile infection].
Topics: Aminoglycosides; Biodiversity; Cause of Death; Colonoscopy; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Hospital Mortality; Humans; Metronidazole; Patient Readmission; Prognosis; Recurrence; Tomography, X-Ray Computed; Transplantation; Vancomycin | 2013 |
Risk estimation for recurrent Clostridium difficile infection based on clinical factors.
Topics: Adult; Age Factors; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Creatine; Female; Fidaxomicin; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Recurrence; Risk Factors; Vancomycin; Young Adult | 2014 |
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Polymers; Recurrence; Sulfonic Acids; Vancomycin; Young Adult | 2014 |
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazolidinones; Patient Safety; Recurrence; Vancomycin | 2015 |
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Pilot Projects; Recurrence; Treatment Outcome; Vancomycin | 2016 |
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Recurrence; Treatment Outcome; Vancomycin | 2016 |
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Humans; Male; Microbiota; Middle Aged; Ontario; Recurrence; Vancomycin; Young Adult | 2017 |
Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Fidaxomicin; Humans; Male; Middle Aged; Molecular Typing; Polymorphism, Restriction Fragment Length; Prohibitins; Recurrence; Treatment Outcome; Vancomycin | 2012 |
Duodenal infusion of donor feces for recurrent Clostridium difficile.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Diarrhea; Duodenum; Feces; Female; Humans; Intubation, Gastrointestinal; Male; Metagenome; Middle Aged; Recurrence; Therapeutic Irrigation; Vancomycin | 2013 |
Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Feces; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Postoperative Complications; Pouchitis; Proctocolectomy, Restorative; Prospective Studies; Recurrence; Risk Factors; Treatment Outcome; Vancomycin | 2013 |
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Remission Induction; Risk Factors; Vancomycin | 2002 |
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin Resistance; Middle Aged; Recurrence; Skin Diseases, Infectious; Streptococcus agalactiae; Treatment Outcome; Vancomycin | 2007 |
Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures.
Topics: Adolescent; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Eruptions; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Premedication; Prospective Studies; Random Allocation; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 1984 |
Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrol
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1995 |
[Antibiotic prophylaxis with ++vancomycin in corrective surgery with alloplastic material].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biocompatible Materials; Hernia, Inguinal; Hernia, Ventral; Humans; Recurrence; Vancomycin | 1995 |
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1996 |
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Risk Factors; Seasons; Vancomycin | 1997 |
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Health Care Costs; Hospitalization; Humans; Incidence; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 1999 |
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cells, Cultured; Clostridium Infections; Feces; Humans; Metronidazole; Placebos; Recurrence; Saccharomyces; Time Factors; Vancomycin | 1999 |
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Probiotics; Recurrence; Saccharomyces; Vancomycin | 2000 |
Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
Topics: Female; Humans; Imipenem; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Vancomycin | 1992 |
Is initial (24 hours) lavage necessary in treatment of CAPD peritonitis?
Topics: Acute Disease; Bacterial Infections; Humans; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Lavage; Peritonitis; Recurrence; Vancomycin | 1991 |
Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin.
Topics: Adult; Cefazolin; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1991 |
Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.
Topics: Catheters, Indwelling; Female; Gentamicins; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Urokinase-Type Plasminogen Activator; Vancomycin | 1989 |
Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Topics: Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1989 |
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
Topics: Antidiarrheals; Clinical Trials as Topic; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin; Yeast, Dried | 1989 |
Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Glycopeptides; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Random Allocation; Recurrence; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1988 |
Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors.
Topics: Aged; Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Colitis; Feces; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Recurrence; Risk; Vancomycin | 1986 |
Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial.
Topics: Aged; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Middle Aged; Random Allocation; Recurrence; Time Factors; Vancomycin | 1986 |
258 other study(ies) available for vancomycin and Recrudescence
| Article | Year |
|---|---|
Salicylanilide Analog Minimizes Relapse of
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Male; Mice; Mice, Inbred C57BL; Recurrence; Safety; Salicylanilides; Tissue Distribution | 2020 |
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Practice Guidelines as Topic; Recurrence; Societies, Medical; Vancomycin | 2021 |
Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study.
Topics: Adult; Aftercare; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Hospital Mortality; Humans; Infant, Newborn; Metronidazole; Patient Discharge; Recurrence; Retrospective Studies; Vancomycin | 2022 |
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridium Infections; Cohort Studies; Fidaxomicin; Humans; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2022 |
Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients.
Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Neoplasms; Recurrence; Retrospective Studies; Vancomycin | 2022 |
Efficacy of Omadacycline or Vancomycin Combined With Germinants for Preventing Clostridioides difficile Relapse in a Murine Model.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Mice; Recurrence; Vancomycin; Weight Loss | 2023 |
The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
Topics: Animals; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Granulocyte Colony-Stimulating Factor; Inflammation Mediators; Interleukin-6; Mice; Raffinose; Recurrence; Treatment Outcome; Tryptophan; Tumor Necrosis Factor-alpha; Valine; Vancomycin | 2022 |
Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Recurrence; Secondary Prevention; Vancomycin | 2023 |
Live fecal microbiota oral capsules (Vowst) for prevention of CDI recurrence.
Topics: Anti-Bacterial Agents; Capsules; Clostridium Infections; Humans; Microbiota; Recurrence; Vancomycin | 2023 |
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Humans; Inflammatory Bowel Diseases; Male; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2023 |
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fecal Microbiota Transplantation; Feces; Humans; Mice; Recurrence; Treatment Outcome; Vancomycin | 2023 |
Risk factors for Recurrent Clostridioides Difficile Infection in Children.
Topics: Anti-Bacterial Agents; Child; Chronic Disease; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2023 |
Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Female; Humans; Intensive Care Units; Male; Metronidazole; Recurrence; Risk Factors; Singapore; Treatment Outcome; Vancomycin | 2019 |
Clinical Predictors of Recurrence After Primary Clostridioides difficile Infection: A Prospective Cohort Study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Vancomycin | 2020 |
Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Hospitalization; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Risk Factors; Vancomycin | 2020 |
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Duration of Therapy; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Recurrence; Vancomycin; Young Adult | 2019 |
Effect of Induced Membrane Formation Followed by Polymethylmethacrylate Implantation on Diabetic Foot Ulcer Healing When Revascularization Is Not Feasible.
Topics: Abscess; Aged; Amputation, Surgical; Anti-Bacterial Agents; Bone Cements; Case-Control Studies; Debridement; Diabetic Foot; Female; Gangrene; Gentamicins; Humans; Male; Membranes; Middle Aged; Osteomyelitis; Peripheral Arterial Disease; Polymethyl Methacrylate; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vancomycin; Wound Healing; Wound Infection | 2019 |
Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease.
Topics: Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridium Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Fecal Microbiota Transplantation; Fidaxomicin; Health Personnel; Hong Kong; Humans; Inflammatory Bowel Diseases; Public Health; Quality-Adjusted Life Years; Recurrence; Treatment Outcome; Vancomycin | 2020 |
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.
Topics: Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Drug Administration Routes; Female; Hospitalization; Hospitals; Humans; Immunoenzyme Techniques; Incidence; Inpatients; Japan; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Vancomycin | 2020 |
Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
Topics: Aged; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Drug Utilization Review; Female; Fidaxomicin; Humans; Japan; Length of Stay; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recurrence; Vancomycin | 2020 |
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Rheumatoid; Auranofin; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Repositioning; Fidaxomicin; Gastrointestinal Tract; Humans; Mice; Microbial Sensitivity Tests; Recurrence; Vancomycin | 2020 |
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2020 |
Mandated IOL Removal for Cure of Recurrent Enterococcus Faecalis Endophthalmitis: A Case Report.
Topics: Aged; Anti-Bacterial Agents; Device Removal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microscopy, Acoustic; Phacoemulsification; Recurrence; Slit Lamp Microscopy; Vancomycin; Visual Acuity; Vitreous Body | 2021 |
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin | 2020 |
Optimal vancomycin dose in the treatment of
Topics: Age Factors; Aged; Aged, 80 and over; Antimicrobial Stewardship; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Serum Albumin; Severity of Illness Index; Sex Factors; Vancomycin | 2021 |
Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients.
Topics: Anti-Bacterial Agents; Cholangitis, Sclerosing; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Colonoscopy; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Vancomycin; Young Adult | 2020 |
Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Fecal Microbiota Transplantation; Humans; Microbiota; Recurrence; Treatment Outcome; Vancomycin | 2020 |
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Fidaxomicin; Hospitalization; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Recurrence; Treatment Outcome; Vancomycin | 2021 |
Recurrent Clostridium difficile infection treated with bezlotoxumab in a liver transplant patient.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Humans; Male; Middle Aged; Recurrence; Vancomycin | 2021 |
Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Utilization; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin | 2021 |
Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent clostridioides difficile.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Comorbidity; Drug Administration Routes; Female; Fidaxomicin; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Vancomycin | 2021 |
Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Standard of Care; Treatment Outcome; Vancomycin | 2021 |
Single-Stage Revision for Chronic Fungal Periprosthetic Joint Infection: An Average of 5 Years of Follow-Up.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Debridement; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Knee Prosthesis; Male; Middle Aged; Mycoses; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Outbreaks; Female; Humans; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Recurrence; Ribotyping; Risk Factors; Spain; Survival Analysis; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
Topics: Adolescent; Adult; Clostridium Infections; Colectomy; Cross-Sectional Studies; Escherichia coli; Feces; Female; Humans; Incidence; Inflammatory Bowel Diseases; Length of Stay; Logistic Models; Male; Middle Aged; New York City; Polymerase Chain Reaction; Recurrence; Vancomycin; Young Adult | 2017 |
Epidemiology of Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Child; Community-Acquired Infections; Female; Hospitalization; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Musculoskeletal Diseases; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Treatment Failure; Vancomycin; Vascular Diseases | 2017 |
Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Female; Humans; Male; Microbiota; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Vancomycin | 2017 |
Vancomycin vs Metronidazole for Clostridium difficile infection: focus on recurrence and mortality.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Risk Assessment; Secondary Prevention; Survival Analysis; Treatment Outcome; United States; Vancomycin | 2017 |
Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Cross Infection; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Medicare; Metronidazole; Patient Readmission; Recurrence; Retrospective Studies; United States; Vancomycin | 2018 |
An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Computer Simulation; Drug Administration Schedule; Drug Dosage Calculations; Humans; Microbial Sensitivity Tests; Models, Statistical; Recurrence; Ribotyping; Spores, Bacterial; Vancomycin | 2017 |
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Topics: Adult; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hematologic Neoplasms; Hospital Units; Hospitals, Teaching; Humans; Immunocompromised Host; Male; Medication Adherence; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin | 2017 |
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Female; Humans; Kidney Transplantation; Male; Middle Aged; Recurrence; Secondary Prevention; Transplant Recipients; Vancomycin | 2018 |
Recurrent bacteremia and liver abscess caused by Clostridium difficile: A case report.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Translocation; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clostridioides difficile; Clostridium Infections; Humans; Liver Abscess; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Metronidazole; Recurrence; Vancomycin | 2017 |
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Cholangitis, Sclerosing; Ciprofloxacin; Drug Therapy, Combination; Humans; Liver Function Tests; Liver Transplantation; Male; Postoperative Complications; Prednisolone; Recurrence; Treatment Outcome; Vancomycin | 2017 |
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Inpatients; Leukocyte Count; Male; Metronidazole; Middle Aged; Neutrophils; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Fecal Microbiota Transplantation; Female; Humans; Male; Middle Aged; Recurrence; Regression, Psychology; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vancomycin; Young Adult | 2018 |
Use of modular megaprosthesis in managing chronic end-stage periprosthetic hip and knee infections: Is there an increase in relapse rate?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Bone Resorption; Bone Transplantation; Female; Femur; Follow-Up Studies; Gentamicins; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Osteomyelitis; Pain, Postoperative; Patient Satisfaction; Prostheses and Implants; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Salvage Therapy; Vancomycin; Young Adult | 2018 |
BILATERAL ENTEROCOCCUS FAECALIS ENDOPHTHALMITIS WITH MULTIPLE RECURRENCES.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Male; Microscopy, Electron; Recurrence; Secondary Prevention; Ultrasonography; Vancomycin; Visual Acuity; Vitrectomy | 2021 |
Repeated Clostridium difficile infection after living donor liver transplantation.
Topics: Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Immunosuppressive Agents; Length of Stay; Liver Transplantation; Living Donors; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Vancomycin | 2018 |
Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Recurrence; Retrospective Studies; Transplant Recipients; Treatment Outcome; Vancomycin | 2018 |
Common variable immunodeficiency presenting in a man with recurrent pneumonia caused by
Topics: Age of Onset; Aged; Anti-Bacterial Agents; Common Variable Immunodeficiency; Drug Resistance, Bacterial; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lung; Male; Pneumonia, Staphylococcal; Recurrence; Staphylococcus lugdunensis; Vancomycin | 2018 |
The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Drug Resistance, Bacterial; Fecal Microbiota Transplantation; Female; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Outcome and Process Assessment, Health Care; Recurrence; South Africa; Vancomycin | 2018 |
Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
Topics: Adult; Age Factors; Ambulatory Care; Anti-Bacterial Agents; Anti-Inflammatory Agents; Brazil; Clostridium Infections; Colitis, Ulcerative; Crohn Disease; Disease Progression; Female; Humans; Infliximab; Male; Middle Aged; Prevalence; Prospective Studies; Recurrence; Risk Factors; Sex Factors; Steroids; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Diagnosis and Treatment of Clostridium difficile Infection.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Nucleic Acid Amplification Techniques; Practice Guidelines as Topic; Recurrence; Vancomycin | 2018 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
A Case of Recurring Diarrhea in a Young Woman.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Recurrence; Vancomycin | 2019 |
Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Recurrence; Retrospective Studies; Severity of Illness Index; Vancomycin | 2019 |
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Female; Fidaxomicin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Treatment Failure; Treatment Outcome; Vancomycin | 2019 |
Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Databases, Factual; Disease Management; Female; Fidaxomicin; Humans; Male; Middle Aged; Propensity Score; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United States; Vancomycin | 2019 |
Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
Recurrent Clostridioides (Clostridium) difficile infection in a patient suffering from inflammatory bowel disease and benefits of resistotyping.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Typing Techniques; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Feces; Humans; Male; Multilocus Sequence Typing; Recurrence; Vancomycin | 2019 |
Recurrent
Topics: Aged; Dexamethasone; DNA, Bacterial; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Recurrence; Vancomycin; Vitreous Body | 2019 |
Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals; Humans; Inpatients; Japan; Logistic Models; Male; Metronidazole; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Logistic Models; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Vancomycin | 2019 |
Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Intestine, Small; Male; Metronidazole; Postoperative Complications; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
Does oral vancomycin prophylaxis during systemic antibiotic exposure prevent Clostridioides difficile infection relapses? Still in search of an answer.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Recurrence; Vancomycin | 2019 |
High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Linezolid; Microbiota; Quorum Sensing; Recurrence; Ribotyping; Spores, Bacterial; Vancomycin; Virulence Factors | 2019 |
A unique case of peroneus brevis/longus myositis in a patient with a STAT3 mutation.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Disease-Free Survival; Humans; Job Syndrome; Male; Muscles; Mutation; Myositis; Recurrence; STAT3 Transcription Factor; Vancomycin | 2013 |
Reconstruction of achilles rerupture with peroneus longus tendon transfer.
Topics: Achilles Tendon; Adult; Anti-Bacterial Agents; Female; Humans; Magnetic Resonance Imaging; Recurrence; Rupture; Staphylococcal Infections; Staphylococcus epidermidis; Tendon Transfer; Vancomycin | 2013 |
Salmonella enterica serovar Minnesota urosepsis in a patient with Crohn's disease in the absence of recent or current gastrointestinal symptoms.
Topics: Adult; Antibodies, Monoclonal; Ceftriaxone; Crohn Disease; Humans; Infliximab; Male; Meropenem; Recurrence; Salmonella enterica; Salmonella Infections; Sepsis; Thienamycins; Urinary Catheters; Urinary Tract Infections; Urolithiasis; Vancomycin | 2013 |
Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2013 |
[Clostridium difficile infection (CDI) in the course of time - an issue only for the internist?].
Topics: Aminoglycosides; Clostridioides difficile; Colectomy; Colostomy; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Germany; Humans; Incidence; Metronidazole; Recurrence; Transplantation; Vancomycin | 2014 |
Industrially prefabricated cement spacers: do vancomycin- and gentamicin-impregnated spacers offer any advantage?
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Chi-Square Distribution; Coated Materials, Biocompatible; Device Removal; Female; Gentamicins; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Prosthesis-Related Infections; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vancomycin | 2014 |
Photo recall reaction following the use of vancomycin.
Topics: Anti-Bacterial Agents; Drug Eruptions; Erythema; Female; Humans; Middle Aged; Recurrence; Sunburn; Vancomycin | 2013 |
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Female; Hospitalization; Hospitals, Teaching; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Romania; Tertiary Care Centers; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Tolerance; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin; Young Adult | 2014 |
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin | 2014 |
Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, University; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Texas; Vancomycin | 2014 |
Recurrent linezolid-resistant Enterococcus faecalis infection in a patient with pneumonia.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Vancomycin; Vancomycin Resistance | 2015 |
Residual renal function in patients on peritoneal dialysis: effect of peritonitis episodes.
Topics: Adult; Aged; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Recurrence; Renal Dialysis; Retrospective Studies; Tobramycin; Vancomycin | 2014 |
Emphysematous cystitis due to recurrent Clostridium difficile infection.
Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cystitis; Emphysema; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Metronidazole; Recurrence; Urinary Bladder; Vancomycin | 2014 |
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzimidazoles; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fidaxomicin; Gastrointestinal Tract; Mesocricetus; Microbial Sensitivity Tests; Plasma; Pyridines; Recurrence; Survival Analysis; Treatment Outcome; Vancomycin | 2015 |
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae.
Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin | 2015 |
Impact of Clostridium difficile recurrence on hospital readmissions.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fluoroquinolones; Humans; Intensive Care Units; Linezolid; Multivariate Analysis; Patient Readmission; Recurrence; Regression Analysis; Retrospective Studies; Vancomycin | 2015 |
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss | 2015 |
Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Biological Therapy; Capsules; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Freezing; Humans; Irritable Bowel Syndrome; Male; Metronidazole; Microbiota; Recurrence; Transplantation, Homologous; Treatment Outcome; Vancomycin | 2015 |
Identification of Recurrent Clostridium difficile Infection Using Administrative Codes: Accuracy and Implications for Surveillance.
Topics: Administrative Claims, Healthcare; Aged; Algorithms; Anti-Bacterial Agents; Area Under Curve; Bacteriological Techniques; Clostridioides difficile; Drug Prescriptions; Enterocolitis, Pseudomembranous; Feces; Female; Humans; International Classification of Diseases; Male; Middle Aged; Population Surveillance; Predictive Value of Tests; Recurrence; ROC Curve; Vancomycin | 2015 |
Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Gastrointestinal Tract; Humans; Middle Aged; Models, Theoretical; Recurrence; Treatment Outcome; Vancomycin | 2015 |
Adynamic ileus and diarrhoea: a rare adverse effect of antidepressants.
Topics: Aged; Anti-Bacterial Agents; Antidepressive Agents; Colonoscopy; Diarrhea; Female; Humans; Iatrogenic Disease; Ileus; Metronidazole; Parenteral Nutrition; Recurrence; Treatment Outcome; Vancomycin | 2015 |
Broncholithiasis presenting as bronchiectasis and recurrent pneumonias.
Topics: Anti-Bacterial Agents; Bronchial Diseases; Bronchiectasis; Bronchoalveolar Lavage; Chest Pain; Dyspnea; Female; Fever; Humans; Lithiasis; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Recurrence; Treatment Outcome; Vancomycin | 2015 |
[Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case].
Topics: Clostridioides difficile; Clostridium Infections; Diarrhea; Fecal Microbiota Transplantation; Female; Humans; Middle Aged; Recurrence; Vancomycin | 2015 |
Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
Topics: Aged; Anti-Bacterial Agents; Axitinib; Carcinoma, Renal Cell; Clostridioides difficile; Costs and Cost Analysis; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Imidazoles; Indazoles; Metronidazole; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Vancomycin; Withholding Treatment | 2015 |
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Metronidazole; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2015 |
Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.
Topics: Anti-Bacterial Agents; Canada; Clostridioides difficile; Cohort Studies; Cost of Illness; Enterocolitis, Pseudomembranous; Hospitalization; Incidence; Metronidazole; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2016 |
Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Propensity Score; Recurrence; Regression Analysis; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2016 |
Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
Topics: Anti-Bacterial Agents; Bacterial Load; Bacteroides fragilis; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Tract; Humans; Microbiota; Models, Biological; Recurrence; Vancomycin | 2016 |
Chronic Recurrent Pseudophakic Endophthalmitis.
Topics: Aged, 80 and over; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Female; Follow-Up Studies; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Recurrence; Risk Assessment; Slit Lamp; Treatment Outcome; Vancomycin; Vitrectomy | 2016 |
Small-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Multilocus Sequence Typing; Phenotype; Recurrence; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2016 |
Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
Topics: Anti-Bacterial Agents; Australia; Clostridioides difficile; Cost Savings; Cost-Benefit Analysis; Drug Costs; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Health Care Costs; Humans; Intestines; Markov Chains; Models, Economic; Quality of Life; Quality-Adjusted Life Years; Recurrence; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Clostridium difficile Associated Diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Vancomycin | 2016 |
[Antibiotic treatment of clostridial colitis].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin | 2016 |
First description of late recurrence of catheter-associated bacteraemia due to Cellulosimicrobium cellulans.
Topics: Actinobacteria; Adenocarcinoma; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Female; Humans; Immunocompromised Host; Middle Aged; Rectal Neoplasms; Recurrence; Vancomycin; Vascular Access Devices | 2017 |
Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Feces; Female; Hospitalization; Hospitals; Humans; Immunoassay; Inflammation; Israel; Leukocyte L1 Antigen Complex; Leukocytosis; Male; Metronidazole; Middle Aged; Recurrence; Ribotyping; Severity of Illness Index; Vancomycin; Young Adult | 2016 |
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Minocycline; Recurrence; Retrospective Studies; Sepsis; Tigecycline; Treatment Outcome; Vancomycin | 2016 |
Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Quebec; Recurrence; Retrospective Studies; Secondary Prevention; Vancomycin; Young Adult | 2016 |
Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Infant; Infant, Newborn; Italy; Male; Metronidazole; Prevalence; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome; Vancomycin | 2017 |
Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Bacteremia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Recurrence; Retrospective Studies; Risk Factors; ROC Curve; Survival Rate; Vancomycin | 2017 |
An institutional comparison of total abdominal colectomy and diverting loop ileostomy and colonic lavage in the treatment of severe, complicated Clostridium difficile infections.
Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Colectomy; Colon; Female; Humans; Ileostomy; Male; Metronidazole; Middle Aged; Organ Sparing Treatments; Recurrence; Retrospective Studies; Severity of Illness Index; Therapeutic Irrigation; Vancomycin; Virginia | 2017 |
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Computer Simulation; Cost-Benefit Analysis; Decision Trees; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; France; Health Care Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Recurrence; Vancomycin | 2017 |
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.
Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; France; Hospitalization; Humans; Markov Chains; Models, Economic; Neoplasms; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; Severity of Illness Index; Vancomycin | 2017 |
Beyond MRSA: the growing menace of hVISA and VISA.
Topics: Anti-Bacterial Agents; Daptomycin; Debridement; Discitis; Drug Resistance, Multiple, Bacterial; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Recurrence; Retreatment; Spinal Diseases; Staphylococcal Infections; Staphylococcus aureus; Thoracic Vertebrae; Vancomycin; Vancomycin Resistance | 2008 |
Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report.
Topics: Arthroplasty, Replacement; Biofilms; Combined Modality Therapy; Debridement; Device Removal; Diagnosis, Differential; Elbow Joint; Fractures, Ununited; Humans; Humeral Fractures; Internal Fixators; Male; Microscopy, Confocal; Middle Aged; Prosthesis Failure; Prosthesis-Related Infections; Radiography; Recurrence; Rifampin; Staphylococcal Infections; Vancomycin | 2008 |
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vancomycin | 2008 |
Relapsing peritonitis with Corynebacterium aquaticum in a boy receiving automated peritoneal dialysis.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Corynebacterium; Corynebacterium Infections; Drug Combinations; Humans; Male; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Treatment Outcome; Vancomycin | 2009 |
Sternectomy and sternum reconstruction for infection after cardiac surgery.
Topics: Cardiac Surgical Procedures; Drainage; Humans; Male; Middle Aged; Pericardial Effusion; Recurrence; Sternum; Surgical Wound Infection; Vancomycin | 2008 |
[Pneumococcal meningitis in children--9 1/2-year-experience at Szent László Hospital, Budapest, Hungary].
Topics: Adolescent; Anti-Bacterial Agents; Ataxia; Ceftriaxone; Child; Child, Preschool; Female; Follow-Up Studies; Hospital Departments; Humans; Hungary; Infant; Infant, Newborn; Intellectual Disability; Intensive Care Units, Pediatric; Length of Stay; Male; Medical Records; Meningitis, Pneumococcal; Muscle Hypotonia; Pneumococcal Vaccines; Recurrence; Respiration, Artificial; Retrospective Studies; Urinary Bladder, Neurogenic; Vaccines, Conjugate; Vancomycin | 2008 |
Varicella reactivation presenting as shingles and aseptic meningitis in an immunocompetent 11-year-old boy.
Topics: Acyclovir; Anti-Bacterial Agents; Antibodies, Viral; Antiviral Agents; Cefotaxime; Chickenpox; Child; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Meningitis, Aseptic; Polymerase Chain Reaction; Recurrence; Spinal Puncture; Vancomycin | 2009 |
[The approach to recurrent infections with Clostridium difficile].
Topics: Anti-Bacterial Agents; Brachytherapy; Clostridioides difficile; Combined Modality Therapy; Complementary Therapies; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin | 2008 |
Recurrent cellulitis in a case of Aagenaes syndrome.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cellulitis; Cholestasis, Intrahepatic; Humans; Ketorolac; Linezolid; Lower Extremity; Lymphedema; Male; Oxazolidinones; Recurrence; Syndrome; Vancomycin | 2009 |
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Netilmicin; Peritoneal Dialysis; Peritonitis; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2009 |
Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation.
Topics: Arthritis; Drug Hypersensitivity; Eosinophilia; Fas Ligand Protein; Fatal Outcome; Granzymes; Humans; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Recurrence; Sulfasalazine; Syndrome; T-Lymphocytes, Cytotoxic; Vancomycin | 2009 |
A refractory case of community-acquired pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Asthma; Community-Acquired Infections; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Staphylococcal; Radiography, Thoracic; Recurrence; Risk Assessment; Sputum; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Child; Child, Preschool; Coagulase; Disinfection; Female; Humans; Infant; Male; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Treatment Outcome; Vancomycin; Withholding Treatment; Young Adult | 2010 |
Stool transplantation for older patients with Clostridium difficile infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Feces; Humans; Omeprazole; Probiotics; Recurrence; Vancomycin | 2009 |
Repeat 2-stage revision for recurrent infection of total hip arthroplasty.
Topics: Adult; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Female; Hip Prosthesis; Humans; Male; Middle Aged; Prosthesis-Related Infections; Recurrence; Reoperation; Tobramycin; Vancomycin | 2010 |
[Effective treatment of recurrent infective endocarditis. Is it always in compliance with the guidelines?].
Topics: Adult; Aminoglycosides; Aortic Valve; Clindamycin; Endocarditis, Bacterial; Gentamicins; Guideline Adherence; Heart Septal Defects, Ventricular; Heart Valve Prosthesis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Peptides; Recurrence; Staphylococcal Infections; Vancomycin | 2010 |
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Recurrence; Ribotyping; Rifampin; Severity of Illness Index; Vancomycin | 2010 |
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2010 |
Endogenous endophthalmitis caused by Enterococcus casseliflavus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA, Bacterial; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Recurrence; Vancomycin; Vitrectomy; Young Adult | 2011 |
Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalosporin Resistance; Coagulase; Humans; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 2010 |
Infection of pacemaker lead by penicillin-resistant Streptococcus Pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Device Removal; Drug Administration Schedule; Endocarditis, Bacterial; Humans; Male; Pacemaker, Artificial; Penicillin Resistance; Pneumococcal Infections; Recurrence; Sepsis; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2011 |
Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterococcus; Enterocolitis, Pseudomembranous; Feces; Female; Hemoglobins; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2011 |
Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Genes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Molecular Typing; Recurrence; Risk Factors; Vancomycin; Young Adult | 2011 |
Antimicrobial use and risk for recurrent Clostridium difficile infection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Metronidazole; Middle Aged; Minnesota; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2011 |
Reinfected revised TKA resolves with an aggressive protocol and antibiotic infusion.
Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Cohort Studies; Debridement; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intra-Articular; Knee Prosthesis; Male; Middle Aged; Prosthesis-Related Infections; Recovery of Function; Recurrence; Reoperation; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Recognizing metronidazole resistant C. difficile.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Opportunistic Infections; Probiotics; Recurrence; Vancomycin | 2011 |
Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Hospital Bed Capacity, 300 to 499; Hospitalization; Hospitals, Private; Humans; Injections, Intravenous; Length of Stay; Medical Records; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Young Adult | 2011 |
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Republic of Korea; Treatment Outcome; Vancomycin | 2011 |
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Vancomycin | 2012 |
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Metagenome; Recurrence; Surveys and Questionnaires; United States; Vancomycin | 2012 |
A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, Military; Humans; Incidence; Inpatients; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Military Medicine; Outpatients; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States; Vancomycin; Veterans | 2012 |
Efficacy of LFF571 in a hamster model of Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Male; Mesocricetus; Recurrence; Thiazoles; Vancomycin | 2012 |
Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Male; Metronidazole; Nitro Compounds; Recurrence; Thiazoles; Vancomycin | 2011 |
Failure mode and effects analysis outputs: are they valid?
Topics: Anti-Bacterial Agents; Critical Pathways; Gentamicins; Health Knowledge, Attitudes, Practice; Hospitals, Teaching; Humans; Infusions, Intravenous; Medication Errors; National Health Programs; Patient Care Team; Qualitative Research; Recurrence; Reproducibility of Results; Risk Assessment; Risk Management; Time Factors; Treatment Failure; United Kingdom; Vancomycin | 2012 |
Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study.
Topics: Anti-Bacterial Agents; Cohort Studies; Daptomycin; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Middle Aged; Osteomyelitis; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2012 |
Antimicrobial activities of fidaxomicin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Feces; Fidaxomicin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Recurrence; Vancomycin | 2012 |
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Creatine; Fever; Fidaxomicin; Humans; Leukocyte Count; Leukocytosis; Odds Ratio; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; ROC Curve; Severity of Illness Index; Time Factors; Treatment Failure; Vancomycin | 2012 |
Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Recurrence; Treatment Outcome; Vancomycin | 2013 |
Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Diagnosis, Differential; Doxycycline; Drug Monitoring; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Staphylococcal Infections; Thrombocytopenia; Vancomycin | 2012 |
Rifaximin in the treatment of recurrent Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Pneumatosis intestinalis in a patient with recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colic; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Pneumatosis Cystoides Intestinalis; Recurrence; Tomography, X-Ray Computed; Vancomycin | 2012 |
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.
Topics: Animals; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Female; Intestines; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Microbial Consortia; Microbial Interactions; Molecular Sequence Data; Probiotics; Recurrence; Vancomycin | 2012 |
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections.
Topics: Administration, Topical; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antisepsis; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Drug Carriers; Drug Therapy, Combination; Follow-Up Studies; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Limb Salvage; Lower Extremity; Male; Middle Aged; Polymethyl Methacrylate; Prosthesis-Related Infections; Recurrence; Retrospective Studies; Tobramycin; Treatment Outcome; Vancomycin | 2013 |
Recurrent methicillin-resistant Staphylococcus aureus wound ulcer after clear-cornea cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Conjunctiva; Corneal Ulcer; Eye Infections, Bacterial; Humans; Lens Implantation, Intraocular; Male; Methicillin Resistance; Phacoemulsification; Postoperative Complications; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps; Surgical Wound Infection; Treatment Outcome; Vancomycin; Visual Acuity | 2002 |
[Endophthalmitis following cataract surgery].
Topics: Amikacin; Cefotaxime; Ceftazidime; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lenses, Intraocular; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitrectomy | 2002 |
[Role of Clostridium difficile infection in the relapse of ulcerative colitis].
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Treatment Outcome; Vancomycin | 2002 |
[Antibiotic-associated diarrhea].
Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Metronidazole; Recurrence; Vancomycin | 2003 |
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amputation, Surgical; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Child; Diabetes Complications; Female; Humans; Infusions, Intravenous; Male; Medical Records; Middle Aged; Osteomyelitis; Outcome Assessment, Health Care; Penicillins; Peripheral Vascular Diseases; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin; Washington | 2003 |
Valproic acid-induced eosinophilic pleural effusion.
Topics: Adult; Anti-Bacterial Agents; Antimanic Agents; Ceftazidime; Chest Pain; Cough; Drainage; Drug Therapy, Combination; Eosinophilia; Eosinophils; Fever; Humans; Leukocyte Count; Male; Pleural Effusion; Recurrence; Schizophrenia; Spinal Puncture; Thoracostomy; Tomography, X-Ray Computed; Valproic Acid; Vancomycin | 2003 |
[Recurrence of bacterial endophthalmitis after penetrating keratoplasty].
Topics: Abscess; Adult; Amphotericin B; Aqueous Humor; Candida albicans; Candidiasis; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Keratoplasty, Penetrating; Male; Postoperative Complications; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body | 2004 |
Recurrent acute rheumatic fever: a forgotten diagnosis?
Topics: Acute Disease; Adult; Amoxicillin; Anti-Inflammatory Agents; Aortic Valve; Aortic Valve Insufficiency; Arthralgia; Bangladesh; Clarithromycin; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Emigration and Immigration; Endocarditis, Bacterial; England; Female; Fever; Gentamicins; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Penicillin G; Penicillin V; Pericarditis; Pharyngitis; Prednisone; Recurrence; Rheumatic Fever; Rheumatic Heart Disease; Rifampin; Unnecessary Procedures; Vancomycin | 2004 |
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess.
Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections; Disease Susceptibility; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hepatitis C; Humans; Male; Methicillin Resistance; Nafcillin; Orchitis; Prostatitis; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Suppuration; Transurethral Resection of Prostate; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
Topics: Anti-Bacterial Agents; Diarrhea; Endoscopy, Gastrointestinal; Enterocolitis, Pseudomembranous; Feces; Humans; Immunoenzyme Techniques; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2004 |
Cervical spondylodiscitis from an ingested pin: a case report.
Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating | 2005 |
Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2005 |
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Middle Aged; Quebec; Recurrence; Risk Factors; Treatment Failure; Vancomycin | 2005 |
The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cloxacillin; Female; Humans; Israel; Male; Methicillin Resistance; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
Topics: Adult; Aged; Anti-Bacterial Agents; Conjunctivitis, Bacterial; Data Collection; Diabetic Foot; Female; Hospitals, University; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Turkey; Vancomycin | 2005 |
[Relapsing infections with Clostridium difficile].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cytotoxins; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 2005 |
Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Fatal Outcome; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Mitral Valve; Oxazolidinones; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2005 |
Case of the month. Chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Biopsy; Cefepime; Cephalosporins; Chronic Disease; Humans; Humerus; Male; Osteomyelitis; Recurrence; Vancomycin | 2005 |
Wide sleeve resection of lower trachea through anterior approach with omentopexy.
Topics: Adult; Anastomosis, Surgical; Anti-Bacterial Agents; Carcinoma, Adenoid Cystic; Encephalitis, Herpes Simplex; Female; Follow-Up Studies; Humans; Intubation, Intratracheal; Male; Methicillin Resistance; Middle Aged; Omentum; Preoperative Care; Recurrence; Respiration, Artificial; Staphylococcal Infections; Staphylococcus aureus; Trachea; Tracheal Neoplasms; Tracheal Stenosis; Vancomycin | 2006 |
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacteriolysis; Hemolysin Proteins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |
Bilateral psoas abscesses post-peripheral blood stem cell transplantation.
Topics: Adult; Cyclosporine; Drainage; Female; Humans; Meropenem; Peripheral Blood Stem Cell Transplantation; Psoas Abscess; Recurrence; Remission Induction; Sensitivity and Specificity; Thienamycins; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin | 2006 |
Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Bone Cements; Female; Gentamicins; Humans; Knee Joint; Knee Prosthesis; Male; Middle Aged; Predictive Value of Tests; Prosthesis-Related Infections; Range of Motion, Articular; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin | 2006 |
Deep sternal wire infection resulting in severe pulmonary valve endocarditis.
Topics: Aged; Bone Wires; Combined Modality Therapy; Coronary Artery Bypass; Debridement; Diagnostic Errors; Endocarditis, Bacterial; Heart Injuries; Heart Ventricles; Humans; Male; Osteitis; Pneumonia; Pulmonary Valve; Pulmonary Valve Insufficiency; Recurrence; Saphenous Vein; Staphylococcal Infections; Sternum; Surgical Wound Dehiscence; Surgical Wound Infection; Suture Techniques; Vancomycin; Ventricular Outflow Obstruction; Wounds, Stab | 2006 |
Reactivation of dormant lumbar methicillin-resistant Staphylococcus aureus osteomyelitis after 12 years.
Topics: Abscess; Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Drug Therapy, Combination; Humans; Intervertebral Disc Displacement; Laminectomy; Linezolid; Lumbar Vertebrae; Male; Methicillin Resistance; Osteomyelitis; Oxazolidinones; Recurrence; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2007 |
[Clostridium difficile associated diarrhea in the elderly patient].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2007 |
A case of recurrent Clostridium difficile diarrhea.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Recurrence; Treatment Failure; Vancomycin | 2007 |
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Topics: Aged; Anti-Bacterial Agents; Chi-Square Distribution; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Metronidazole; Quebec; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
Topics: Adolescent; Anti-Bacterial Agents; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Injections, Intravenous; Injections, Intraventricular; Medical Records; Meningitis; Recurrence; Staphylococcal Infections; Sterilization; Vancomycin | 2007 |
The changing face of Clostridium difficile: what treatment options remain?
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Quebec; Recurrence; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis.
Topics: Aged; Anti-Infective Agents; Discitis; Female; Humans; Leukocyte Count; Male; Methicillin Resistance; Middle Aged; Neurosurgical Procedures; Recurrence; Retrospective Studies; Risk Factors; Sepsis; Sex Distribution; Spine; Staphylococcal Infections; Staphylococcus aureus; Survival Rate; Vancomycin | 2007 |
Pseudomembranous colitis with recurring diarrhoea and prolonged persistence of Clostridium difficile in a 10-year-old girl.
Topics: Amoxicillin; Carrier State; Child; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Recurrence; Vancomycin | 1984 |
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Recurrence; Vancomycin | 1980 |
Treatment of recurrent antibiotic-associated pseudomembranous colitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin | 1982 |
Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease.
Topics: Clostridium; Endotoxins; Feces; Humans; Inflammation; Intestinal Diseases; Recurrence; Vancomycin | 1981 |
Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Male; Metronidazole; Recurrence; Vancomycin | 1981 |
A second relapse of Clostridium difficile colitis.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1981 |
Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy.
Topics: Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Recurrence; Vancomycin | 1981 |
Pseudomembranous colitis: multiple relapses after treatment with metronidazole.
Topics: Aged; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1981 |
Treatment of Clostridium difficile colitis and diarrhea with vancomycin.
Topics: Adolescent; Adult; Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Infant, Newborn; Male; Middle Aged; Recurrence; Vancomycin | 1981 |
Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Clostridium; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Middle Aged; Recurrence; Vancomycin | 1980 |
Relapse of antibiotic-associated colitis after vancomycin therapy.
Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1980 |
Vancomycin therapy for Clostridium difficile.
Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Recurrence; Vancomycin | 1980 |
Vancomycin therapy Clostridium difficile.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1980 |
Relapse of Clostridium colitis after vancomycin therapy.
Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1980 |
Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea.
Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Recurrence; Saccharomyces cerevisiae; Vancomycin | 1995 |
Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
Topics: Gram-Positive Bacterial Infections; Humans; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1995 |
Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Ceftriaxone; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Penicillins; Rabbits; Random Allocation; Recurrence; Teicoplanin; Vancomycin | 1995 |
Management and control of a large outbreak of diarrhoea due to Clostridium difficile.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; England; Enterotoxins; Hospitals, General; Humans; Infection Control; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1994 |
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Contraindications; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; France; Humans; Immunocompromised Host; Leukocyte Count; Mycoses; Neutropenia; Recurrence; Teicoplanin; Time Factors; Vancomycin | 1994 |
[Clostridium difficile in early childhood ulcerative pancolitis].
Topics: Biopsy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Infant; Intestinal Mucosa; Male; Prednisone; Recurrence; Sulfasalazine; Vancomycin | 1993 |
[Recurrent abscess of the lung caused by Rhodococcus equi in an HIV-positive patient: response to the combination imipenem/vancomycin].
Topics: Actinomycetales Infections; Adult; Drug Therapy, Combination; HIV Seropositivity; Humans; Imipenem; Lung Abscess; Male; Recurrence; Rhodococcus equi; Vancomycin | 1993 |
Prevention of recurrent central venous catheter infections with a novel flush solution in a patient on long-term hemodialysis.
Topics: Bacteremia; Catheterization, Central Venous; Child, Preschool; Ciprofloxacin; Drug Therapy, Combination; Heparin; Humans; Kidney Failure, Chronic; Longitudinal Studies; Male; Recurrence; Renal Dialysis; Vancomycin | 1993 |
Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Humans; Male; Methicillin Resistance; Middle Aged; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 1996 |
Relapses or reinfections: analysis of a case of Clostridium difficile-associated colitis by two typing systems.
Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Female; Humans; Immunoblotting; Recurrence; Vancomycin | 1996 |
Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Leukemia, Promyelocytic, Acute; Male; Recurrence; Vancomycin | 1997 |
Serious infections caused by multiply-resistant Enterococcus faecium.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Liver Transplantation; Male; Recurrence; Sepsis; Vancomycin | 1995 |
Recurrent endophthalmitis after cataract surgery with a scleral-tunnel incision.
Topics: Administration, Topical; Aged; Cataract Extraction; Cefazolin; Cornea; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections; Keratitis; Recurrence; Sclera; Staphylococcal Infections; Staphylococcus; Suture Techniques; Vancomycin; Vitreous Body | 1998 |
Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1998 |
Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
Topics: Adult; Aged; Anti-Bacterial Agents; Audiometry, Pure-Tone; Auditory Threshold; Caloric Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hearing Loss, Sensorineural; Humans; Male; Metabolic Clearance Rate; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1998 |
Vancomycin-impregnated polymethylmethacrylate beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: report of two cases.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Neoplasms; Chondrosarcoma; Drug Implants; Female; Humans; Male; Methicillin; Methicillin Resistance; Microspheres; Middle Aged; Osteomyelitis; Penicillins; Polymethyl Methacrylate; Radiography; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 1998 |
Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Linear Models; Male; Metronidazole; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Time Factors; Treatment Failure; Vancomycin | 1998 |
Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1999 |
A desperate case of failing vascular access--management of superior vena cava thrombosis, recurrent bacteraemia, and acute clavicular osteomyelitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Clavicle; Equipment Failure; Humans; Male; Osteomyelitis; Phlebography; Recurrence; Renal Dialysis; Tomography, X-Ray Computed; Vancomycin; Venae Cavae; Venous Thrombosis | 1999 |
Treatment of peritonitis in pediatric continuous peritoneal dialysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Child; Humans; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Teicoplanin; Vancomycin | 1999 |
The conservative management of corynebacterium group D2 encrusted pyelitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Corynebacterium Infections; Humans; Kidney Calculi; Middle Aged; Pyelitis; Recurrence; Therapeutic Irrigation; Tomography, X-Ray Computed; Vancomycin | 1999 |
Treatment strategies for postoperative Propionibacterium acnes endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Combined Modality Therapy; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Propionibacterium acnes; Recurrence; Reoperation; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 1999 |
Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis.
Topics: Bacteriolysis; Cephalosporins; Female; Head; Humans; Infant; Magnetic Resonance Imaging; Meningitis, Pneumococcal; Recurrence; Spine; Tomography; Vancomycin; Vancomycin Resistance | 2000 |
Epidemic Bacillus endophthalmitis after cataract surgery II: chronic and recurrent presentation and outcome.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus; Chronic Disease; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2000 |
[Recurrent Clostridium difficile enterocolitis].
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunoglobulins, Intravenous; Metronidazole; Recurrence; Saccharomyces; Vancomycin | 2000 |
Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis.
Topics: Adult; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recombinant Proteins; Recurrence; Remission Induction; Tissue Plasminogen Activator; Vancomycin | 2001 |
Infection of central nervous system by motile Enterococcus: first case report.
Topics: Aged; Central Nervous System Bacterial Infections; Drug Therapy, Combination; Enterococcus; Fever; Gentamicins; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Male; Meningitis; Microbial Sensitivity Tests; Recurrence; Vancomycin; Ventriculoperitoneal Shunt | 2001 |
Liver abscess caused by Clostridium difficile.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drainage; Female; Humans; Liver Abscess; Metronidazole; Recurrence; Treatment Failure; Vancomycin | 2001 |
Prophylaxis against staphylococcal infection before tertiary knee joint replacement.
Topics: Antibiotic Prophylaxis; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Knee Joint; Middle Aged; Preoperative Care; Prosthesis Failure; Prosthesis-Related Infections; Recurrence; Reoperation; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2001 |
Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty.
Topics: Adult; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Cefotaxime; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Treatment Outcome; Vancomycin | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colon; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Recurrence; Tomography, X-Ray Computed; Ultrasonography; Vancomycin | 2002 |
Relapse of pseudomembranous colitis after vancomycin therapy.
Topics: Administration, Oral; Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1979 |
Single-antibiotic therapy for streptococcal endocarditis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalothin; Child; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Humans; Infusions, Parenteral; Injections, Intramuscular; Middle Aged; Penicillin G; Penicillin G Procaine; Penicillin V; Recurrence; Streptococcal Infections; Streptococcus; Vancomycin | 1979 |
Relapse of pseudomembranous colitis after vancomycin therapy.
Topics: Administration, Oral; Adult; Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Recurrence; Time Factors; Vancomycin | 1979 |
Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis.
Topics: Adolescent; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Fosfomycin; Humans; Infant; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vancomycin | 1992 |
Medical cure of a brainstem abscess and serial brainstem auditory evoked potentials.
Topics: Brain Abscess; Brain Stem; Child; Chloramphenicol; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Humans; Reaction Time; Recurrence; Tomography, X-Ray Computed; Vancomycin | 1992 |
Long-term, intraperitoneal vancomycin in the prevention of recurrent peritonitis during CAPD: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Humans; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Time Factors; Vancomycin | 1991 |
Delayed-onset pseudophakic endophthalmitis.
Topics: Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Lenses, Intraocular; Prednisolone; Propionibacterium acnes; Recurrence; Vancomycin; Vitrectomy | 1991 |
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.
Topics: Adult; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Staphylococcal Infections; Substance Abuse, Intravenous; Vancomycin | 1990 |
Urokinase: a treatment for relapsing peritonitis due to coagulase-negative staphylococci.
Topics: Bacterial Typing Techniques; Drug Therapy, Combination; Follow-Up Studies; Humans; Length of Stay; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Urokinase-Type Plasminogen Activator; Vancomycin | 1989 |
Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine.
Topics: Bacterial Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Diarrhea, Infantile; Drug Therapy, Combination; Enterotoxins; Female; Humans; Infant; Male; Recurrence; Vancomycin | 1989 |
Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefazolin; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Risk Factors; Vancomycin | 1989 |
Treatment of Clostridium difficile diarrhea.
Topics: Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 1989 |
Rhodococcus peritonitis in a patient treated with peritoneal dialysis.
Topics: Actinomycetales Infections; Cefazolin; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Recurrence; Rhodococcus; Vancomycin | 1989 |
Short-course therapy for catheter-associated Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Catheterization; Cephalothin; Cross Infection; Endocarditis, Bacterial; Follow-Up Studies; Humans; Oxacillin; Prospective Studies; Recurrence; Risk Factors; Sepsis; Staphylococcal Infections; Time Factors; Vancomycin | 1989 |
Enterococcal osteomyelitis in the diabetic patient.
Topics: Diabetes Complications; Drug Resistance, Microbial; Enterococcus faecalis; Foot Diseases; Humans; Male; Middle Aged; Osteomyelitis; Recurrence; Streptococcal Infections; Vancomycin | 1986 |
Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Nafcillin; Recurrence; Sepsis; Staphylococcal Infections; Substance-Related Disorders; Tobramycin; Vancomycin | 1988 |
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.
Topics: Animals; Bacterial Proteins; Bacterial Toxins; Clostridium; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Latex Fixation Tests; Recurrence; Saccharomyces; Vancomycin | 1987 |
Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.
Topics: Aged; Aged, 80 and over; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1987 |
Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
Topics: Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Colitis; Diarrhea; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Vancomycin | 1987 |
Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Child; Child, Preschool; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Vancomycin | 1986 |
Antibiotic-associated colitis: why do patients relapse?
Topics: Bacitracin; Colitis; Humans; Metronidazole; Recurrence; Vancomycin | 1986 |
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridium; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Recurrence; Spores, Bacterial; Vancomycin | 1985 |
Clinical value of antistaphylococcal drugs.
Topics: Acute Disease; Anti-Infective Agents; Cephalosporins; Chronic Disease; Czechoslovakia; Drug Evaluation; Endocarditis, Bacterial; Erythromycin; Fusidic Acid; Gentamicins; Humans; Lincomycin; Novobiocin; Osteomyelitis; Penicillins; Recurrence; Rifamycins; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Vancomycin | 1973 |